vs
Side-by-side financial comparison of REED'S, INC. (REED) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.
REED'S, INC. is the larger business by last-quarter revenue ($7.5M vs $4.8M, roughly 1.6× Scilex Holding Co). REED'S, INC. runs the higher net margin — -50.5% vs -961.9%, a 911.4% gap on every dollar of revenue. On growth, REED'S, INC. posted the faster year-over-year revenue change (-23.1% vs -67.8%). Over the past eight quarters, REED'S, INC.'s revenue compounded faster (-11.7% CAGR vs -33.6%).
Waddell & Reed Financial, Inc. was an American asset management and financial planning company founded in 1937 in Kansas City, Missouri. It was a publicly traded company from 1998 to 2021, and briefly had its headquarters in Overland Park, Kansas, and was planning a move back to Downtown Kansas City before the company was sold. It operated asset management and distribution subsidiaries, including Ivy Investment Management Company and Waddell & Reed Investment Management Company.
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
REED vs SCLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.5M | $4.8M |
| Net Profit | $-3.8M | $-46.1M |
| Gross Margin | 20.4% | 45.5% |
| Operating Margin | -46.9% | -2317.8% |
| Net Margin | -50.5% | -961.9% |
| Revenue YoY | -23.1% | -67.8% |
| Net Profit YoY | 8.2% | -613.7% |
| EPS (diluted) | $-1.26 | $-4.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.5M | $4.8M | ||
| Q3 25 | $7.0M | $10.6M | ||
| Q2 25 | $9.5M | $9.9M | ||
| Q1 25 | $10.0M | $5.0M | ||
| Q4 24 | $9.7M | $14.9M | ||
| Q3 24 | $6.8M | $14.4M | ||
| Q2 24 | $11.9M | $16.4M | ||
| Q1 24 | $9.6M | $10.9M |
| Q4 25 | $-3.8M | $-46.1M | ||
| Q3 25 | $-4.0M | $-257.8M | ||
| Q2 25 | $-6.0M | $-44.0M | ||
| Q1 25 | $-2.0M | $-26.1M | ||
| Q4 24 | $-4.1M | $-6.5M | ||
| Q3 24 | $-4.2M | $-4.4M | ||
| Q2 24 | $-3.2M | $-37.6M | ||
| Q1 24 | $-1.7M | $-24.4M |
| Q4 25 | 20.4% | 45.5% | ||
| Q3 25 | 17.4% | 68.5% | ||
| Q2 25 | 8.5% | 66.9% | ||
| Q1 25 | 33.9% | 72.3% | ||
| Q4 24 | 30.0% | 68.5% | ||
| Q3 24 | 18.0% | 73.9% | ||
| Q2 24 | 32.3% | 73.2% | ||
| Q1 24 | 35.6% | 64.7% |
| Q4 25 | -46.9% | -2317.8% | ||
| Q3 25 | -58.3% | -1766.2% | ||
| Q2 25 | -60.8% | -207.2% | ||
| Q1 25 | -17.4% | -557.5% | ||
| Q4 24 | -37.6% | -190.5% | ||
| Q3 24 | -46.5% | -138.0% | ||
| Q2 24 | -5.6% | -95.4% | ||
| Q1 24 | -6.8% | -179.0% |
| Q4 25 | -50.5% | -961.9% | ||
| Q3 25 | -56.6% | -2441.5% | ||
| Q2 25 | -63.5% | -445.1% | ||
| Q1 25 | -20.3% | -521.2% | ||
| Q4 24 | -42.3% | -43.4% | ||
| Q3 24 | -61.5% | -30.4% | ||
| Q2 24 | -27.1% | -229.6% | ||
| Q1 24 | -17.4% | -224.0% |
| Q4 25 | $-1.26 | $-4.63 | ||
| Q3 25 | $-0.48 | $-22.17 | ||
| Q2 25 | $-0.13 | $-7.42 | ||
| Q1 25 | $-0.04 | $-2.26 | ||
| Q4 24 | $-3.73 | $8.53 | ||
| Q3 24 | $-4.91 | $-0.58 | ||
| Q2 24 | $-0.77 | $-7.67 | ||
| Q1 24 | $-0.40 | $-8.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $5.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.2M | $-207.8M |
| Total Assets | $23.3M | $365.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.0M | ||
| Q3 25 | — | $878.0K | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $77.0K | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $1.8M |
| Q4 25 | $9.2M | $-207.8M | ||
| Q3 25 | $2.8M | $-176.9M | ||
| Q2 25 | $1.7M | $-249.0M | ||
| Q1 25 | $4.7M | $-211.5M | ||
| Q4 24 | $6.6M | $-192.6M | ||
| Q3 24 | $-22.0M | $-211.3M | ||
| Q2 24 | $-23.8M | $-214.7M | ||
| Q1 24 | $-20.7M | $-189.8M |
| Q4 25 | $23.3M | $365.0M | ||
| Q3 25 | $19.9M | $275.9M | ||
| Q2 25 | $23.7M | $83.8M | ||
| Q1 25 | $24.5M | $79.0M | ||
| Q4 24 | $25.1M | $93.0M | ||
| Q3 24 | $15.0M | $100.4M | ||
| Q2 24 | $18.7M | $104.5M | ||
| Q1 24 | $19.3M | $91.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.8M | $-17.5M |
| Free Cash FlowOCF − Capex | $-3.9M | — |
| FCF MarginFCF / Revenue | -52.0% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-17.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.8M | $-17.5M | ||
| Q3 25 | $-2.8M | $8.2M | ||
| Q2 25 | $-5.0M | $7.0M | ||
| Q1 25 | $-5.4M | $6.0M | ||
| Q4 24 | $-3.9M | $2.5M | ||
| Q3 24 | $1.1M | $5.1M | ||
| Q2 24 | $-912.0K | $2.3M | ||
| Q1 24 | $-2.4M | $9.4M |
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $-2.9M | — | ||
| Q2 25 | $-5.1M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $-4.0M | — | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $-924.0K | — | ||
| Q1 24 | $-2.4M | — |
| Q4 25 | -52.0% | — | ||
| Q3 25 | -41.5% | — | ||
| Q2 25 | -53.2% | — | ||
| Q1 25 | -54.2% | — | ||
| Q4 24 | -40.8% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | -7.8% | — | ||
| Q1 24 | -25.1% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.2% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
